SCHEMBL20670738

SCHEMBL20670738

O=C1CCCCCCCC/C=C\CCCCCCCCCN1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 3/20 0.70
FKBP5 Q13451 1/20 0.70
OR51E2 Q9H255 1/20 0.58
KDM4E B2RXH2 2/20 0.44
GAA P10253 1/20 0.44
POLB P06746 1/20 0.44
ALDH1A1 P00352 2/20 0.33
CCR2 P41597 1/20 0.33
MERTK Q12866 1/20 0.33
TRIM24 O15164 1/20 0.31
TRIM33 Q9UPN9 1/20 0.31
CTSD P07339 2/20 0.30
HDAC3 O15379 1/20 0.30
HDAC4 P56524 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC7 Q8WUI4 1/20 0.30
HDAC2 Q92769 1/20 0.30
HDAC10 Q969S8 1/20 0.30
HDAC11 Q96DB2 1/20 0.30
HDAC8 Q9BY41 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2741403 1.00 CRBN (0.70) CRBNFKBP5OR51E2KDM4EGAA
SCHEMBL9351391 1.00 CRBN (0.70) CRBNFKBP5OR51E2KDM4EGAA
SCHEMBL8467530 1.00 CRBN (0.70) CRBNFKBP5OR51E2KDM4EGAA
SCHEMBL14125456 0.96 CRBN (0.62) CRBNFKBP5OR51E2KDM4EGAA
SCHEMBL17395304 0.96 CRBN (0.62) CRBNFKBP5OR51E2KDM4EGAA
SCHEMBL17395305 0.96 CRBN (0.62) CRBNFKBP5OR51E2KDM4EGAA
SCHEMBL17395306 0.96 CRBN (0.62) CRBNFKBP5OR51E2KDM4EGAA
SCHEMBL14125454 0.96 CRBN (0.62) CRBNFKBP5OR51E2KDM4EGAA
SCHEMBL17395319 0.91 CRBN (0.56) CRBNFKBP5OR51E2KDM4EGAA
SCHEMBL14232888 0.91 CRBN (0.56) CRBNFKBP5OR51E2KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200123197-A1 METHOD OF MAKING A CROSS METATHESIS PRODUCT NATIONAL SCIENCE FOUNDATION 2020-04-23 US disclosed
WO-2019018773-A1 METHOD OF MAKING A CROSS METATHESIS PRODUCT TRUSTEES OF BOSTON COLLEGE (US) 2019-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200123197-A1 METHOD OF MAKING A CROSS METATHESIS PRODUCT DUOX2, DUOX1, RNF168 CRBN 2499/4885FKBP5 1669/4885OR51E2 1648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.